Molecular Genetics of Kidney Stone Disease
DOI:
https://doi.org/10.14456/tjg.2014.9Keywords:
Kidney stone disease, Nephrolithiasis, Genetic association study, Single nucleotide polymorphisms, Candidate geneAbstract
Kidney stone disease (KSD) is a multifactorial disease caused by a complex interaction of genetic and environmental factors. It causes significant morbidity and medical care expenses worldwide, which can be found commonly in tropical territory including Thailand. A majority of kidney stones are composed of calcium and it is usually associated with a metabolic abnormality such as hypercalciurea, hyperoxaurea, hyperphosphaturia, hyperuricosuria, hypocitraturea, and a defect of urinary acidification. However, few defects associated with monogenic forms of KSD have been identified. To date, molecular genetic studies to investigate genetic contribution of multifactorial KSD have been extensively performed and a number of causative genes have been recognized, but they vary among populations. In Thailand, the highest prevalence of KSD was observed in the Northeastern (NE) area. Its etiology and pathogenesis are still obscure and unique characteristics with no conditions of increased urinary solutes such as hypercalciurea, hyperoxaurea, and hyperuricosuria that are different from what has been reported in other ethnic groups are shown. The study to identify causative genes will provide more understanding of pathogenesis underlying KSD and also the unique pathogenesis of KSD in NE Thai patients. These will lead to improved quality and efficiency of patient care, diagnosis, prevention and control of diseases and complications. The knowledge of reported monogenic and multifactorial KSD, and the update on molecular genetic studies to investigate genes responsible for the disease in NE Thai patients are reviewed in this article.References
Aegukkatajit S (1999) Reduction of urinary stone in children from north-eastern Thailand. J Med Assoc Thai 82: 1230–1233.
Aksoy H, Aksoy Y, Ozturk N, Aydin HR, Yildirim AK, Akcay F (2010) Fetuin-A gene polymorphism in patients with calcium oxalate stone disease. Urology 75: 928–932.
Attanasio M (2011) The genetic components of idiopathic nephrolithiasis. Pediatr Nephrol 26: 337–346.
Batlle D, Ghanekar H, Jain S, Mitra A (2001) Hereditary distal renal tubular acidosis: new understandings. Annu Rev Med 52: 471–484.
Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, Frappier D, Burkett K, Carpenter TO, Anderson D, et al. (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78: 179–192.
Besbas N, Ozaltin F, Jeck N, Seyberth H, Ludwig M (2005) CLCN5 mutation (R347X) associated with hypokalemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent's disease. Nephrol Dial Transplant 20: 1476–1479.
Bruce LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ, Wrong O, Tanner MJ (1997) Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 100: 1693–1707.
Carr G, Simmons N, Sayer J (2003) A role for CBS domain 2 in trafficking of chloride channel CLC-5 Biochem Biophys Res Commun 310: 600–605.
Cellini B, Oppici E, Paiardini A, Montioli R (2012) Molecular insights into primary hyperoxaluria type 1 pathogenesis. Front Biosci (Landmark Ed) 17: 621–634.
Chen WC, Wu HC, Lu HF, Tsai FJ (2001a) Calcitonin receptor gene polymorphism: a possible genetic marker for patients with calcium oxalate stones. Eur Urol 39: 716–719.
Chen WC, Chen HY, Lu HF, Hsu CD, Tsai FJ (2001b) Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease. BJU Int 87: 168–171.
Chen WC, Wu HC, Chen HY, Wu MC, Hsu CD, Tsai FJ (2001c) Interleukin-1 gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res 29: 321–324.
Chen WC, Wu HC, Lin WC, Wu MC, Hsu CD, Tsai FJ (2001d) The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men. BJU Int 88: 432–436.
Chen WC, Chen HY, Wu HC, Wu MC, Hsu CD, Tsai FJ (2003) Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease. Urol Res 31: 218–222.
Cho HY, Lee BH, Choi HJ, Ha IS, Choi Y, Cheong HI (2008) Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol 23: 243–249.
Chou YH, Woon PY, Chen WC, Hsu YW, Chang JM, Hwang DY, Chiu YC, Kuo HC, Chang WP,
Hou MF, et al. (2011) A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis. PLoS One 6: e25227.
Clubbe WH (1872) Hereditariness of stone. Lancet 99: 204.
Coe FL, Evan A, Worcester E (2005) Kidney stone disease. J Clin Invest 115: 2598–2608.
Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP (1999) The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 8: 2063–2069.
Danpure CJ, Lumb MJ, Birdsey GM, Zhang X (2003) Alanine: glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease. Biochim Biophys Acta 1647: 70–75.
Danpure CJ, Rumsby G (2004) Molecular aetiology of primary hyperoxaluria and its implications for clinical management. Expert Rev Mol Med 6: 1–16.
Devonald MA, Smith AN, Poon JP, Ihrke G, Karet FE (2003) Non-polarized targeting of AE1 causes autosomal dominant distal renal tubular acidosis. Nat Genet 33: 125–127.
Devuyst O, Jouret F, Auzanneau C, Courtoy PJ (2005) Chloride channels and endocytosis: new insights from Dent's disease and ClC-5 knockout mice. Nephron Physiol 99: 69–73.
Edvardsson VO, Palsson R, Indridason OS, Thorvaldsson S, Stefansson K (2009) Familiality of kidney stone disease in Iceland. Scand J Urol Nephrol 43: 420–424.
Falconer GF, Adams CW (1965) The relationship between nutritional state and severity of atherosclerosis. Guys Hosp Rep 114: 130–139.
Gao B, Yasui T, Itoh Y, Li Z, Okada A, Tozawa K,
Hayashi Y, Kohri K (2007) Association of osteopontin gene haplotypes with nephrolithiasis. Kidney Int 72: 592–598.
Gilissen C, Hoischen A, Brunner HG, Veltman JA (2012) Disease gene identification strategies for exome sequencing. Eur J Hum Genet 20: 490–497.
Goldfarb DS, Fischer ME, Keich Y, Goldberg J. (2005) A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 67: 1053–1061.
Gudbjartsson DF, Holm H, Indridason OS, Thorleifsson G, Edvardsson V, Sulem P, de Vegt F, d'Ancona FC, den Heijer M, Wetzels JF, et al. (2010) Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet 6: e1001039.
Gunther W, Piwon N, Jentsch TJ (2003) The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease. Pflugers Arch 445: 456–462.
Hara-Chikuma M, Wang Y, Guggino SE, Guggino WB, Verkman AS (2005) Impaired acidification in early endosomes of ClC-5 deficient proximal tubule. Biochem Biophys Res Commun 329: 941–946.
Hebert SC (2003) Bartter syndrome. Curr Opin Nephrol Hypertens 12: 527–532.
Herring LC (1962) Observations on the analysis of ten thousand urinary calculi. J Urol 88: 545–562.
Hunter DJ, Lange Md, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD (2002) Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (Lond) 103: 259–265.
Jentsch TJ, Neagoe I, Scheel O (2005) CLC chloride
channels and transporters. Curr Opin Neurobiol 15: 319–325.
Karet FE, Gainza FJ, Györy AZ, Unwin RJ, Wrong O, Tanner MJ, Nayir A, Alpay H, Santos F, Hulton SA, et al. (1998) Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A 95: 6337–6342.
Karet FE, Finberg KE, Nelson RD, Nayir A, Mocan H, Sanjad SA, Rodriguez-Soriano J, Santos F, Cremers CW, Di Pietro A, et al. (1999) Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 21: 84–90.
Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, Lesslauer A, Vitzthum H, Suzuki Y, Luk JM, Becker C, et al. (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79: 949–957.
Laing CM, Toye AM, Capasso G, Unwin RJ (2005) Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol 37: 1151–1161.
Langman CB (2004) The molecular basis of kidney stones. Curr Opin Pediatr 16: 188–193.
Liu CC, Huang SP, Tsai LY, Wu WJ, Juo SH, Chou YH, Huang CH, Wu MT (2010) The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin Chim Acta 411: 739–743.
Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, et al. (1996) A common molecular basis for three inherited kidney stone diseases. Nature 379: 445–449.
Loredo-Osti JC, Roslin NM, Tessier J, Fujiwara TM, Morgan K, Bonnardeaux A (2005) Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int 68: 966–971.
Lu X, Gao B, Liu Z, Tian X, Mao X, Emmanuel N, Zhu Q, Xiao C (2012) A polymorphism of matrix Gla protein gene is associated with kidney stone in the Chinese Han population. Gene 511: 127-130.
McGeown MG (1960) Heredity in renal stone disease. Clin Sci 19: 465–471.
Mittal RD, Bid HK, Manchanda PK, Kapoor R (2007) Association of interleukin-1beta gene and receptor antagonist polymorphisms with calcium oxalate urolithiasis. J Endourol 21: 1565–1570.
Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367: 333–344.
Monga M, Macias B, Groppo E, Hargens A (2006) Genetic heritability of urinary stone risk in identical twins. J Urol 175: 2125–2128.
Müller D, Kausalya PJ, Claverie-Martin F, Meij IC, Eggert P, Garcia-Nieto V, Hunziker W (2003) A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 73: 1293–1301.
Nimmannit S, Malasit P, Susaengrat W, Ong-Aj-Yooth S, Vasuvattakul S, Pidetcha P, Shayakul C, Nilwarangkur S (1996) Prevalence of endemic distal renal tubular acidosis and renal stone in the northeast of Thailand. Nephron 72: 604–610.
Nishiyama K, Funai T, Katafuchi R, Hattori F, Onoyama K, Ichiyama A (1991) Primary hyperoxaluria type I due to a point mutation of T to C in the coding region of the serine:pyruvate aminotransferase gene. Biochem Biophys Res Commun 176: 1093–1099.
Oppici E, Roncador A, Montioli R, Bianconi S, Cellini B (2013) Gly161 mutations associated with primary hyperoxaluria type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine: glyoxylate amino-transferase. Biochim Biophys Acta 1832: 2277–2288.
Pearce SH1, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, et al. (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335: 1115–1122.
Quilty JA, Cordat E, Reithmeier RA (2002) Impaired trafficking of human kidney anion exchanger (kAE1) caused by hetero-oligomer formation with a truncated mutant associated with distal renal tubular acidosis. Biochem J 368: 895–903.
Resnick M, Pridgen DB, Goodman HO (1968) Genetic predisposition to formation of calcium oxalate renal calculi. N Engl J Med 278: 1313–1318.
Rungroj N, Devonald MA, Cuthbert AW, Reimann F, Akkarapatumwong V, Yenchitsomanus PT, Bennett WM, Karet FE (2004) A novel missense mutation in AE1 causing autosomal dominant distal renal tubular acidosis retains normal transport function but is mistargeted in polarized epithelial cells. J Biol Chem 279: 13833–13838.
Rungroj N, Sritippayawan S, Thongnoppakhun W, Paemanee A, Sawasdee N, Nettuwakul C, Sudtachat N, Ungsupravate D, Praihirunkit P, Chuawattana D, et al. (2011) Prothrombin haplotype associated with kidney stone disease in Northeastern Thai patients. Urology 77: 249.e17-23.
Rungroj N, Sudtachat N, Nettuwakul C, Sawasdee N, Praditsap O, Jungtrakoon P, Sritippayawan S, Chuawattana D, Borvornpadungkitti S, Predanon C, et al. (2012) Association between human prothrombin variant (T165M) and kidney stone disease. PLoS One 7: e45533.
Scheinman SJ, Cox JP, Lloyd SE, Pearce SH, Salenger PV, Hoopes RR, Bushinsky DA, Wrong O, Asplin JR, Langman CB, et al. (2000) Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria. Kidney Int 57: 232–239.
Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP (1996a) Bartter's syndrome hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13: 183–188.
Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP (1996b) Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14: 152–156.
Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, et al. (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17: 171–178.
Smith AN, Skaug J, Choate KA, Nayir A, Bakkaloglu A, Ozen S, Hulton SA, Sanjad SA, Al-Sabban EA, Lifton RP, et al. (2000) Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet 26: 71–75.
Sriboonlue P, Prasongwattana V, Tungsanga K, Tosukhowong P, Phantumvanit P, Bejraputra O, Sitprija V. (1991) Blood and urinary aggregator and inhibitor composition in controls and renal-stone patients from northeastern Thailand. Nephron 59: 591–596.
Sriboonlue P, Prasongwatana V, Chata K, Tungsanga K (1992) Prevalence of upper urinary tract stone disease in a rural community of north-eastern Thailand. Br J Urol 69: 240–244.
Sritippayawan S, Borvornpadungkitti S, Paemanee A, Predanon C, Susaengrat W, Chuawattana D, Sawasdee N, Nakjang S, Pongtepaditep S, Nettuwakul C, et al. (2009) Evidence suggesting a genetic contribution to kidney stone in northeastern Thai population. Urol Res 37: 141–146.
Stechman MJ, Loh NY, Thakker RV (2009) Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol 24: 2321–2332.
Stover EH, Borthwick KJ, Bavalia C, Eady N, Fritz DM, Rungroj N, Giersch AB, Morton CC, Axon PR, Akil I, et al. (2002) Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet 39:796–803.
Strachan T, Read AP (1999) Human molecular genetics. 2nd ed. Wiley-Liss, New York.
Tan M, Xia S, Zhang Q, Zhu J, Bao E (2013) The -160C>a polymorphism in E-cadherin is associated with the risk of nephrolithiasis. PLoS One 8: e73109.
Thakker RV (2000) Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome. Exp Nephrol 8: 351–360.
Thakker RV (2004) Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 35: 275–282.
Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de Vegt F, d'Ancona FC, et al. (2009) Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41: 926–930.
Tore S, Casula S, Casu G, Concas MP, Pistidda P, Persico I, Sassu A, Maestrale GB, Mele C, Caruso MR, et al. (2011) Application of a new method for GWAS in a related case/control sample with known pedigree structure: identification of new loci for nephrolithiasis. PLoS Genet 7: e1001281.
Trinchieri A, Mandressi A, Luongo P, Coppi F, Pisani E (1988) Familial aggregation of renal calcium stone disease. J Urol 139: 478–481.
Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162: 27–30.
Tsai FJ, Lin CC, Lu HF, Chen HY, Chen WC (2002) Urokinase gene 3'-UTR T/C polymorphism is associated with urolithiasis. Urology 59: 458–461.
Tsai FJ, Wu HC, Chen HY, Lu HF, Hsu CD, Chen WC (2003) Association of E-cadherin gene 3'-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int 70: 278–281.
Urabe Y, Tanikawa C, Takahashi A, Okada Y, Morizono T, Tsunoda T, Kamatani N, Kohri K, Chayama K, Kubo M, et al. (2012) A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible Loci at 5q35.3, 7p14.3, and 13q14.1. PLoS Genet 8: e1002541.
Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren ML, Paloschi V, Giannini S, Mignogna G, Rubinacci A, et al. (2007) R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 71: 1155–1162.
Vezzoli G, Terranegra A, Rainone F, Arcidiacono T, Cozzolino M, Aloia A, Dogliotti E, Cusi D, Soldati L (2011) Calcium-sensing receptor and calcium kidney stones. J Transl Med 9: 201.
Waldegger S, Jeck N, Barth P, Peters M, Vitzthum H, Wolf K, Kurtz A, Konrad M, Seyberth HW (2002) Barttin increases surface expression and changes current properties of ClC-K channels. Pflugers Arch 444: 411–418.
Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T (2002) Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360: 692–694.
Wrong OM, Norden AG, Feest TG (1994) Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87: 473–493.
Yanagawa M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue P, Prasongwattana V, Borwornpadungkitti S (1997) Incidence of urolithiasis in northeast Thailand. Int J Urol 4: 537–540.
Yasui T, Okada A, Urabe Y, Usami M, Mizuno K, Kubota Y, Tozawa K, Sasaki S, Higashi Y, Sato Y, et al. (2013) A replication study for three nephrolithiasis loci at 5q35.3, 7p14.3 and 13q14.1 in the Japanese population. J Hum Genet 58: 588–593.
Yenchitsomanus PT, Vasuvattakul S, Kirdpon S, Wasanawatana S, Susaengrat W, Sreethiphayawan S, Chuawatana D, Mingkum S, Sawasdee N, Thuwajit P, et al. (2002) Autosomal recessive distal renal tubular acidosis caused by G701D mutation of anion exchanger 1 gene. Am J Kidney Dis 40: 21–29.
